소프트젤 캡슐 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2032년)

The global demand for Softgel Capsules Market is presumed to reach the market size of nearly USD 16.82 Billion by 2032 from USD 8.88 Billion in 2023 with a CAGR of 7.36% under the study period 2024-2032.

A softgel capsule is a type of capsule that is typically used to hold liquid or powdered medicine and dissolves more quickly than a hard gelatin capsule. Its primary constituents are gelatine films that have been plasticized with sorbitol, glycerine, or a similar polyol. Soft gel capsules are usually taken by mouth. Softgel capsules come in various shapes, including oval, round, oblong, tubs, and suppository. Softgel capsules are becoming more popular among patients who have trouble swallowing and consuming medications in other forms, like kids and the elderly.

MARKET DYNAMICS

Softgel capsules have taken the place of more difficult-to-manufacture capsules. As a result, the market's expansion is expected to accelerate. The nutraceutical industry's massive demand is expected to drive the softgel capsule market's growth trajectory. Softgel capsules have been shown to be the best formulation for poorly soluble medications and increase the absorption time of most therapeutic compounds. Softgel capsules have gained popularity due to their advantages over tablets and other oral forms. Factors affecting its widespread acceptability include ease of swallowing, flavour masking, better bioavailability, non-reactivity, visually pleasing appearance, and longer shelf life. All these elements are boosting the market growth significantly. The market is being propelled forward by rising demand from health-conscious consumers. Moreover, manufacturers are actively developing innovative empty softgel capsules that are more adaptable and convenient for pharmaceutical, nutraceutical, and cosmeceutical uses, further augmenting the market growth. However, the constraints impeding market expansion are the low stability of softgel capsules containing water-soluble chemicals and the significant price volatility of softgel capsules.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Softgel Capsules. The growth and trends of Softgel Capsules industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Softgel Capsules market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Gelatin-Based/Animal-Based
• Non-Animal-Based

By Application

• Antacid And Anti-Flatulent Preparation
• Anti-Anemic Preparations
• Anti-Inflammatory Drugs
• Antibiotic And Antibacterial Drugs
• Cough And Cold Preparations
• Health Supplement
• Vitamin And Dietary Supplement
• Pregnancy

By End-use

• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Contract Manufacturing Organizations

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Softgel Capsules market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Softgel Capsules market include Fuji Capsule, Sirio Pharma Co. Ltd., Captek Softgel International Inc., Thermo Fisher Scientific Inc., EyePoint Pharmaceuticals Inc., Catalent Inc., EuroCaps, Aenova Group, Lonza Capsules & Health Ingredients, ProCaps Laboratories LLC, Soft Gel Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. SOFTGEL CAPSULES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SOFTGEL CAPSULES MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data Analysis By Type
• 5.3. Gelatin-Based/Animal-Based Historic and Forecast Sales By Regions
• 5.4. Non-Animal-Based Historic and Forecast Sales By Regions

6. GLOBAL SOFTGEL CAPSULES MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Antacid And Anti-Flatulent Preparation Historic and Forecast Sales By Regions
• 6.4. Anti-Anemic Preparations Historic and Forecast Sales By Regions
• 6.5. Anti-Inflammatory Drugs Historic and Forecast Sales By Regions
• 6.6. Antibiotic And Antibacterial Drugs Historic and Forecast Sales By Regions
• 6.7. Cough And Cold Preparations Historic and Forecast Sales By Regions
• 6.8. Health Supplement Historic and Forecast Sales By Regions
• 6.9. Vitamin And Dietary Supplement Historic and Forecast Sales By Regions
• 6.10. Pregnancy Historic and Forecast Sales By Regions

7. GLOBAL SOFTGEL CAPSULES MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-use
• 7.2. Historical and Forecast Data Analysis By End-use
• 7.3. Pharmaceutical Companies Historic and Forecast Sales By Regions
• 7.4. Nutraceutical Companies Historic and Forecast Sales By Regions
• 7.5. Cosmeceutical Companies Historic and Forecast Sales By Regions
• 7.6. Contract Manufacturing Organizations Historic and Forecast Sales By Regions

8. GLOBAL SOFTGEL CAPSULES MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE SOFTGEL CAPSULES COMPANIES

• 9.1. Softgel Capsules Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF SOFTGEL CAPSULES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Fuji Capsule
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Sirio Pharma Co. Ltd.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Captek Softgel International Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Thermo Fisher Scientific Inc.
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. EyePoint Pharmaceuticals Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Catalent Inc.
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. EuroCaps
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Aenova Group
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Lonza Capsules & Health Ingredients
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. ProCaps Laboratories LLC
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Soft Gel Technologies Inc
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies